Related Articles
Guillain‑Barre syndrome induced by pembrolizumab and sunitinib: A case report
Pseudoprogression presenting as intestinal perforation in non‑small cell lung cancer treated with anti‑PD‑1: A case report
Anti‑PD‑1 immune checkpoint inhibitor inducing endocrine toxicity in a patient with advanced lung cancer: A case report and literature review
Facial nerve injury immune‑related adverse events associated with adjuvant pembrolizumab therapy: A case report
Pembrolizumab-induced autoimmune encephalitis in a patient with advanced non-small cell lung cancer: A case report